| Financial Year |
March 31 2023 |
| Monetary Funds |
892,965,116.17 |
| Held-for-trading Financial Assets |
320,548,869.83 |
| Notes Receivable |
-- |
| Accounts Receivable |
73,358,534.51 |
| Advances to Suppliers |
3,389,764.14 |
| Other Receivables |
6,831,661.55 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
153,518,938.36 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
40,325,456.76 |
| Total Current Assets |
1,490,938,341.32 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
40,372,341.11 |
| Investment Properties |
-- |
| Fixed Assetes |
94,301,763.52 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
8,843,579.28 |
| R&D expenses |
-- |
| Goodwill |
7,557,161.95 |
| Long-Term Deferred and Prepaid Expenses |
527,488.82 |
| Deferred Income Tax Assets |
37,505,782.02 |
| Other Non-Current Assets |
31,987,337.44 |
| Sub-Total of Non-Current Assets |
221,095,454.14 |
| Total Assets |
1,712,033,795.46 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
6,154,211.86 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
12,224,285.61 |
| Taxes Payable |
18,251,464.55 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
35,889,420.22 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
4,752,868.46 |
| Sub-Total of Current Liabilities |
312,498,981.16 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
75,337.04 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
75,337.04 |
| Total Liabilities |
312,574,318.20 |
| Paid-In Capital(Or Share Stock) |
171,279,516.00 |
| Capital Surplus |
485,619,231.54 |
| Surplus Reserve |
85,639,758.00 |
| LESS:Treasury Stock |
35,530,760.00 |
| Undistributed Profits |
682,015,677.61 |
| Minority Stockholder's Interest |
10,436,054.11 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,389,023,423.15 |
| Owner's Equity（Stockholder's Equity） |
1,399,459,477.26 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,712,033,795.46 |
